Camlin Fine Sciences (NSE:CAMLINFINE) Total Stockholders Equity: ₹10,409 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CAMLINFINE Camlin Fine Sciences Ltd NSE:CAMLINFINE
62 GF Score
Price ₹125.71
GF Value ₹143.80
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Camlin Fine Sciences Total Stockholders Equity?

Camlin Fine Sciences NSE:CAMLINFINE -3.41% 62 Total Stockholders Equity is ₹10,409 Mil as of Mar. 2026. GuruFocus rates NSE:CAMLINFINE with a GF Score™ of 62/100 and a GF Value™ of ₹143.80 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Camlin Fine Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2026 was ₹10,409 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Camlin Fine Sciences's Book Value per Share for the quarter that ended in Mar. 2026 was ₹54.19. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Camlin Fine Sciences's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.69.

Camlin Fine Sciences  (NSE:CAMLINFINE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Camlin Fine Sciences's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(10408.801-0)/192.092
=54.19

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Camlin Fine Sciences's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3830.845 + 3370.081) / 10408.801
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camlin Fine Sciences Total Stockholders Equity Related Terms

Camlin Fine Sciences Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Camlin Fine Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camlin Fine Sciences Total Stockholders Equity Chart

Camlin Fine Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,479.34 8,193.74 8,647.51 9,016.73 10,408.80

Camlin Fine Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,016.73 0.00 8,895.73 0.00 10,408.80
NSE:CAMLINFINE
62GF Score
Camlin Fine Sciences Ltd NSE:CAMLINFINE
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ₹10,409 Mil mean?
Camlin Fine Sciences (NSE:CAMLINFINE) has a Total Stockholders Equity of ₹10,409 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Camlin Fine Sciences and its competitors.
Is Camlin Fine Sciences' Total Stockholders Equity too high?
Camlin Fine Sciences' current Total Stockholders Equity is ₹10,409 Mil. Overall, Camlin Fine Sciences has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camlin Fine Sciences' Total Stockholders Equity compare to LIN and SHW?
Camlin Fine Sciences' Total Stockholders Equity of ₹10,409 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Chemicals company?
A good Total Stockholders Equity depends on the Chemicals industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Camlin Fine Sciences and its competitors. Camlin Fine Sciences's current Total Stockholders Equity is ₹10,409 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camlin Fine Sciences stock overvalued right now?
Based on GuruFocus' analysis, Camlin Fine Sciences (NSE:CAMLINFINE) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹143.80, compared to a current price of ₹125.71 — trading 12.6% below its estimated fair value. The current Total Stockholders Equity is ₹10,409 Mil. Camlin Fine Sciences' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Camlin Fine Sciences (NSE:CAMLINFINE), the current Total Stockholders Equity is ₹10,409 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?

Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued. The current stock price of ₹125.71 is trading 12.6% below its estimated GF Value™ of ₹143.80. GuruFocus considers Camlin Fine Sciences to be Modestly Undervalued.

Key valuation signals for NSE:CAMLINFINE:

  • Total Stockholders Equity: ₹10,409 Mil
  • GF Value™: ₹143.80 vs. price of ₹125.71 (12.6% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Camlin Fine Sciences Business Description

Other Exchanges 532834:India
Address CST Road, Kalina, Floor 2 to 5, In GS Point, Santacruz East, Mumbai, MH, IND, 400 098
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
62GF Score

Get the complete analysis for NSE:CAMLINFINE

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹125.71
Price
₹143.80
GF Value